Clinical Trials Browser

Colonic Neoplasms × dostarlimab × 90 days × Clear all

NCT06567782 2026-03-12

AZUR-4

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT06830239 2026-02-12

Superhero

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT05855200 2026-01-23

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms